Biotechnology company Dendreon Corp. said Friday the Food and Drug Administration will make a regulatory decision on the potential prostate cancer vaccine Provenge by May 1.
Dendreon's Provenge gets FDA review dateCourtesy Newsvine - business Fri, 11/20/2009 - 09:54
Biotechnology company Dendreon Corp. said Friday the Food and Drug Administration will make a regulatory decision on the potential prostate cancer vaccine Provenge by May 1. Tags:
Related itemsDiet Treatment, Already in Use, to Get F.D.A. Review
Mead Johnson Says Its Tests Show Enfamil Baby Formula...
Retiring Amgen CEO Kevin Sharer to Hand Role to...
Samsung SCX-4200 3-in-1 True Multifunction Printer
BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
|
Popular by tags WeekMonth |
Post new comment